In Japan, innovative technology add-on payments are granted for devices with significant clinical benefits that exceed existing technologies. Manufacturers apply through MHLW, providing robust evidence of safety, efficacy, & cost-effectiveness. Chuikyo reviews the application, and if approved, the device receives premium reimbursement pricing under the NHI system to reflect its innovation.
